ES8702949A1 - Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas. - Google Patents

Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas.

Info

Publication number
ES8702949A1
ES8702949A1 ES547495A ES547495A ES8702949A1 ES 8702949 A1 ES8702949 A1 ES 8702949A1 ES 547495 A ES547495 A ES 547495A ES 547495 A ES547495 A ES 547495A ES 8702949 A1 ES8702949 A1 ES 8702949A1
Authority
ES
Spain
Prior art keywords
cyclosporine
cyclosporins
monoclonal antibodies
cyclosporings
succinimidooxysuccinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547495A
Other languages
English (en)
Other versions
ES547495A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848425040A external-priority patent/GB8425040D0/en
Priority claimed from GB858515673A external-priority patent/GB8515673D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8702949A1 publication Critical patent/ES8702949A1/es
Publication of ES547495A0 publication Critical patent/ES547495A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ANTICUERPOS MONOCLONALES A CICLOSPORINAS. COMPRENDE LAS SIGUIENTES ETAPAS: A) CULTIVAR UNA LINEA DE CELULAS HIBRIDOMAS PRODUCTORAS DEL ANTICUERPO MONOCLONAL; Y B) RECUPERAR EL ANTICUERPO ASI OBTENIDO; DONDE ESTOS ANTICUERPOS SON CAPACES DE DISTINGUIR ENTRE UNA CICLOSPORINA PREDETERMINADA, TAL COMO CYCLOSPORINE, DIHIDRO-VAL2-CYCLOSPORINE O NVA2-CYCLOSPORINE, Y UN METABOLITO DE LA MISMA, TAL COMO AL MENOS UN METABOLITO DE LA MISMA EN EL HOMBRE, TAL COMO, EN EL CASO DE CYCLOSPORINE, EL METABOLITO CYCLOSPORINE 1, 8, 9, 10, 16, 17, 18 O 21, Y, EN PARTICULAR, 17. TIENE UTILIDAD EN KITS O SISTEMAS DE DIAGNOSTICO/ANALISIS, ASI COMO CON NUEVAS LINEAS DE CELULAS HIBRIDOMAS UTILIZADAS EN LA PRODUCCION DE DICHOS ANTICUERPOS MONOCLONALES.
ES547495A 1984-10-04 1985-10-02 Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas. Expired ES8702949A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848425040A GB8425040D0 (en) 1984-10-04 1984-10-04 Organic compounds
GB858515673A GB8515673D0 (en) 1985-06-20 1985-06-20 Organic compounds

Publications (2)

Publication Number Publication Date
ES8702949A1 true ES8702949A1 (es) 1987-01-16
ES547495A0 ES547495A0 (es) 1987-01-16

Family

ID=26288301

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547495A Expired ES8702949A1 (es) 1984-10-04 1985-10-02 Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas.

Country Status (15)

Country Link
EP (4) EP0314862A1 (es)
JP (1) JPH074269B2 (es)
KR (1) KR910002691B1 (es)
AT (1) ATE92501T1 (es)
AU (4) AU589917B2 (es)
CA (1) CA1309671C (es)
CY (2) CY1915A (es)
DE (2) DE3587342T2 (es)
DK (1) DK172037B1 (es)
ES (1) ES8702949A1 (es)
FI (1) FI93965C (es)
HK (2) HK78696A (es)
NO (1) NO173557C (es)
NZ (1) NZ213680A (es)
WO (1) WO1986002080A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
AU4958590A (en) * 1988-12-05 1990-07-10 Trustees Of Columbia University In The City Of New York, The Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
EP0473961B1 (en) * 1990-08-15 1996-01-03 Abbott Laboratories Immunoassay reagents and method for determining cyclosporine
ES2091301T3 (es) 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
USRE40596E1 (en) * 1993-04-08 2008-12-02 Novartis Ag Rapamycin assay
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
AU8918998A (en) 1997-08-26 1999-03-16 Wisconsin Alumni Research Foundation Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
ATE312843T1 (de) 1998-07-01 2005-12-15 Debiopharm Sa Neues cyclosporin mit verbesserter wirkung
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
CN1319105A (zh) 1998-10-09 2001-10-24 伊索技术公司 制备针对环孢菌素及其代谢物特异性区域的抗体的方法
WO2003033526A2 (en) 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs
EP2174137B1 (en) 2007-05-24 2011-11-30 Abbott Laboratories Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
WO2009141738A2 (en) * 2008-05-23 2009-11-26 The University Of British Columbia Modified drugs for use in liposomal nanoparticles
EP2391376A4 (en) 2009-01-30 2012-08-01 Enanta Pharm Inc ANALOGUES OF CYCLOSPORIN FOR PREVENTING OR TREATING HEPATITIS C INFECTION
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012145426A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
CN105579046A (zh) 2013-08-26 2016-05-11 英安塔制药有限公司 用于预防或治疗丙型肝炎的环孢菌素类似物
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection
EP3247378B8 (en) 2015-01-09 2023-08-23 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
JP7411326B2 (ja) 2015-10-01 2024-01-11 ワープ ドライブ バイオ インコーポレイテッド タンパク質－タンパク質インターフェースを分析するための方法および試薬
ES2921056T3 (es) 2016-04-12 2022-08-17 Warp Drive Bio Inc Composiciones y métodos para la producción de compuestos
CA3042231A1 (en) 2016-10-28 2018-05-03 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
AU2020379731A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
EP4055028A1 (en) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras inhibitors
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
KR20230067635A (ko) 2020-09-15 2023-05-16 레볼루션 메디슨즈, 인크. 암의 치료에서 ras 억제제로서 인돌 유도체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211526A (en) 1922-09-22 1924-02-22 John Fletcher Holliday Improvements in and relating to chain grate stokers
US4210581A (en) 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
CH614931A5 (es) 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0098457B1 (en) 1980-02-14 1987-08-05 Sandoz Ag (1s,2r,3r)- and (1r,2s,3s)-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes useful in the total synthesis of cyclosporins and processes for their production
IL62965A0 (en) 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
EP0056782B1 (en) 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
GB8407618D0 (en) 1984-03-23 1984-05-02 Sandoz Ltd Organic compounds
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
DK261386D0 (da) 1986-06-03
FI93965C (fi) 1995-06-26
AU589917B2 (en) 1989-10-26
FI862370A0 (fi) 1986-06-03
EP0198026A1 (en) 1986-10-22
EP0314861A1 (en) 1989-05-10
CY1927A (en) 1997-05-16
EP0290762A1 (en) 1988-11-17
JPS62500383A (ja) 1987-02-19
DE3587342T2 (de) 1993-12-02
AU3914189A (en) 1989-11-16
NO862177D0 (no) 1986-06-02
WO1986002080A1 (en) 1986-04-10
AU3914289A (en) 1989-10-26
NO862177L (no) 1986-08-04
NO173557B (no) 1993-09-20
FI93965B (fi) 1995-03-15
AU3914389A (en) 1989-11-16
EP0198026B1 (en) 1993-08-04
CA1309671C (en) 1992-11-03
KR910002691B1 (ko) 1991-05-03
JPH074269B2 (ja) 1995-01-25
ES547495A0 (es) 1987-01-16
DK261386A (da) 1986-06-03
ATE92501T1 (de) 1993-08-15
NO173557C (no) 1993-12-29
DE3587505D1 (de) 1993-09-09
FI862370A (fi) 1986-06-03
HK124696A (en) 1996-07-19
EP0290762B1 (en) 1993-05-12
KR870700637A (ko) 1987-12-30
DE3587505T2 (de) 1994-01-05
DE3587342D1 (en) 1993-06-17
NZ213680A (en) 1990-05-28
CY1915A (en) 1985-09-27
EP0314862A1 (en) 1989-05-10
AU4967185A (en) 1986-04-17
HK78696A (en) 1996-05-10
DK172037B1 (da) 1997-09-22

Similar Documents

Publication Publication Date Title
ES8702949A1 (es) Procedimiento para la produccion de anticuerpos monoclonales a ciclosporinas.
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
CA2107553A1 (en) Monoclonal antibodies to stem cell factor receptors
AU1750297A (en) Humanized green fluorescent protein genes and methods
CA2102301A1 (en) Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
EP0376746A3 (en) Gene family of tumor-associated antigens
CA2049089A1 (en) Immunoassay reagents and method for determining cyclosporine
AU4270796A (en) Improvements in or relating to endometrial function
WO1995000552B1 (en) Prostaglandin receptor ep3 and dna encoding it
IL129139A0 (en) Vertebrate smoothened proteins
EP1026237A3 (en) Tau/neurofilament protein kinases pk40 & pk36
AU7165891A (en) Tumor-specific, cell surface-binding monoclonal antibodies
EP0207165A4 (en) POLYPEPTIDE SECRETION VECTOR, MICROORGANISMS TRANSFORMED BY SAID VECTOR, AND PROCESS FOR THE PREPARATION OF POLYPEPTIDES WITH SAID MICROORGANISMS.
FR2574184B1 (fr) Composes fluorescents, derives d'(amino-4 disulfonato-3,6) naphtalimide, leur application aux dosages immunologiques en polarisation de fluorescence
ATE66534T1 (de) Nortriptylinderivate, verfahren zu ihrer herstellung, deren konjugate mit antigenischen proteinen und enzymen, antikoerper davon und verwandte verfahren zur bestimmung.
IL141858A0 (en) Diagnostic method for detecting disturbances of the pancreas
NO965347L (no) Fremgangsmåte for fremstilling av cytolytiske T-celler som er spesifikke for et peptid/MHC-kompleks
IL76150A (en) Derivatives of aminochromancarboxylic acid and their preparation
WO1999019358A3 (de) Antikörper gegen baculoviren
CA2156397A1 (en) Rapamycin assay
MD728G2 (ro) Preparat pentru determinarea factorului de floculare a stafilococilor
AU1153195A (en) Nucleotide sequences encoding a novel stem cell marker protein, amino acid sequences of the protein, methods for expressing the protein, a composition of isolated protein, and antibodies specific to the protein
CA2204266A1 (en) Purified papillomavirus proteins

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061120